Evaluation of seven tests for the rapid detection of multidrug-resistant tuberculosis in Uganda

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 7, 2010, Pages 890-895

  Bwanga, F ^a,b,c   Joloba, M L ^a   Haile, M ^b,c   Hoffner, Sven ^b,c  

^a MAKERERE UNIVERSITY   (Uganda)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Drug susceptibility testing; Drug resistant tuberculosis; M. tuberculosis; MDR TB

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ISONIAZID; NITRATE REDUCTASE; RESAZURIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ARTICLE; ASSAY; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COLORIMETRY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG RESISTANT TUBERCULOSIS; DRUG SENSITIVITY; ENZYME ASSAY; GENOTYPE; HUMAN; LUNG TUBERCULOSIS; MICROSCOPIC OBSERVATION DRUG SUSCEPTIBILITY; MICROSCOPY; MULTIDRUG RESISTANCE; MYCOBACTERIUM GROWTH INDICATOR TUBE 960; MYCOBACTERIUM TUBERCULOSIS; NITRATE REDUCTASE ASSAY; NONHUMAN; OBSERVATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UGANDA; COMPARATIVE STUDY; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; TIME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; UGANDA;

EID: 77953635043     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. World Health Organization. WHO report 2008. Global tuberculosis control: surveillance, planning, financing. WHO/HTM/ TB/2008.393. Geneva, Switzerland: WHO, 2008.
2. World Health Organization. Anti-tuberculosis drug resistance in the world. Report no 4. WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. WHO/HTM/ TB/2008.394. Geneva, Switzerland: WHO, 2008.
3. Centers for Disease Control and Prevention. Notice to readers: revised definition of extensively drug-resistant tuberculosis. MMWR 2006; 55: 1176.
4. Ängeby K A, Klintz L, Hoffner S E. Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J Clin Microbiol 2002; 40: 553-555.
5. Caviedes L, Lee T S, Gilman R H, et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. J Clin Microbiol 2000; 38: 1203-1208.
6. Moore D A, Evans C A, Gilman R H, et al. Microscopico bservation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006; 355: 1539-1550.
7. Reisner B S, Gatson A M, Woods G L. Evaluation of Mycobacteria Growth Indicator Tubes for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampicin. Diagn Microbiol Infect Dis 1995; 22: 325-329.
8. Hillemann D, Rüsch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007; 45: 2635-2640.
9. Martin A, Portaels F, Palomino J C. Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 59: 175-183.
10. Montoro E, Lemus D, Echemendia M, Martin A, Portaels F, Palomino J C. Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis. J Antimicrob Chemother 2005; 55: 500-505.
11. Martin A, Panaiotov S, Portaels F, Hoffner S, Palomino J C, Ängeby K. The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2008; 62: 56-64.
12. Ling D I, Zwerling A A, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a metaanalysis. Eur Respir J 2008; 32: 1165-1174.
13. Bwanga F, Hoffner S, Haile M, Joloba M L. Direct susceptibility testing for multidrug-resistant tuberculosis: a meta-analysis. BMC Infect Dis 2009; 9: 67.
14. Knotterus J, Weel C. General Introduction: evaluation of diagnostic procedures. In: Knotterus J, ed. The evidence base of clinical diagnosis. 1st ed. London, UK: BMJ Publishing Group, 2002: pp 9-10.
15. Canetti G, Froman F, Grosset J. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 1963; 29: 565-578.
16. BD Diagnostic Systems. BACTEC™ MGIT 960 SIRE kit for the antimycobacterial susceptibility testing of Mycobacterium tuberculosis. Franklin Lakes, NJ, USA: BD Diagnostic Systems. http://www.bd.com/ds/technicalCenter/ clsi/clsi-960sire.pdf Accessed April 2010.
17. Palomino J C, Portaels F. Simple procedure for drug susceptibility testing of Mycobacterium tuberculosis using a commercial colorimetic assay. Eur J Clin Microbiol Infect Dis 1999; 18: 380-383.
18. Hain Lifescience. GenoType MTBDRplus, version 1.0. Nehren, Germany: Hain Lifescience. http://www.hain-lifescience.de/en/ downloads/microbiology.html Accessed February 2008.
19. Lemus D, Montoro E, Echemendia M, Martin A, Portaels F, Palomino J C. Nitrate reductase assay for detection of drug resistance in Mycobacterium tuberculosis: simple and inexpensive method for low-resource laboratories. J Med Microbiol 2006; 55: 861-863.
20. Coban A Y, Birinci A, Ekinci B, Durupinar B. Drug susceptibility testing of Mycobacterium tuberculosis with nitrate reductase assay. Int J Antimicrob Agents 2004; 24: 304-306.
21. Quezada C M, Kamanzi E, Mukamutara J, et al. Implementation validation performed in Rwanda to determine whether the INNO-LiPA Rif.TB line probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in lowr esource countries. J Clin Microbiol 2007; 45: 3111-3114.
22. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman M E. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008; 177: 787-792.
23. Acuna-Villaorduna C, Vassall A, Henostroza G, et al. Cost effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middleincome countries. Clin Infect Dis 2008; 47: 487-495.
24. Nic Fhogartaigh C J, Vargas-Prada S, Huancare V, Lopez S, Rodriguez J, Moore D A. Physician-initiated courtesy MODS testing for TB and MDR-TB diagnosis and patient management. Int J Tuberc Lung Dis 2008; 12: 555-560.
25. Martin A, Varaine F, Von Groll, et al. Thin layer agar method for rapid detection of resistance to rifampicin, ofl oxacin and kanamycin in M. tuberculosis. Int J Tuberc Lung Dis 2008; 12 (Suppl 2): S188 [Abstract PS-81739-19].